Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 60, Issue 9, Pages 5130-5134Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00264-16
Keywords
-
Categories
Funding
- Veterans Affairs Research and Development
- HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [R01AI100560, R01AI072219, R01AI063517]
- HHS \ NIH \ National Center for Advancing Translational Sciences (NCATS) [UL1TR000439]
Ask authors/readers for more resources
Stenotrophomonas maltophilia is an emerging multidrug-resistant (MDR) opportunistic pathogen for which new antibiotic options are urgently needed. We report our clinical experience treating a 19-year-old renal transplant recipient who developed prolonged bacteremia due to metallo-beta-lactamase-producing S. maltophilia refractory to conventional treatment. The infection recurred despite a prolonged course of colistimethate sodium (colistin) but resolved with the use of a novel drug combination with clinical efficacy against the patient's S. maltophilia isolate.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available